Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
What does the safety data say so far
Researchers commonly study GHK-Cu transdermal patches to explore: Evaluation of transdermal tripeptide-copper complex delivery matrices in vitro Permeation and release-kinetics characterization of GHK-Cu in patch substrates Copper-peptide complex stability and integrity during transdermal delivery GHK-Cu interactions with skin extracellular matrix and collagen-related pathways Extracellular matrix signaling and tissue remodeling models Comparative bioavailability across delivery formats in research models As a well-characterized tripeptide-metal complex in a novel delivery format, GHK-Cu transdermal patches serve as a research tool for investigating copper-peptide pharmacokinetics, matrix stability, and tissue-level signaling under controlled laboratory conditions
In a large retrospective cohort study including over 1.6 million patients with Type 2 Diabetes, with no prior diagnosis of obesity associated cancers, a significantly reduced risk in 10 out of 13 obesity associated cancers was reported with the use of GLP-1 agonists, including esophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, pancreatic cancer, meningioma, and multiple myeloma 17
Length indicates how deep the needle penetrates
Best insurance concierge Ro $145+/mo
It's a GLP-1 receptor agonist that is absorbed under the tongue, offering a convenient daily treatment option for those who prefer to avoid injections while still receiving the benefits of semaglutide therapy
